Advisory Board | HBA

Advisory Board

HBA San Diego is excited to have engaged prestigious and insightful partners to help us navigate the challenges and opportunities of our growing chapter. The advisory board will assist the chapter in its strategic direction by providing industry viewpoint and guidance. 
The HBA San Diego advisory board for 2018 - 2019 is comprised of:

Jorgine Ellerbrock, senior vice president operations, Hologic, Inc. (Retired)
Ms. Ellerbrock is a seasoned executive with more than 30 years of experience in operations and commercial management specializing in leadership of global teams, facility consolidation, operational start-ups, lean manufacturing, change leadership and team development. Ms. Ellerbrock will serve a dual role as a member of the HBA pacific regional advisory board.
Grace Park, PhD, director, R&D – product engineering, BD
Dr. Park is a biomedical engineer with more than 10 years of experience managing a worldwide product engineering project portfolio from pipeline management, prioritization, execution, metrics roll-up to reporting for a global medical device business platform including team development of R&D and quality engineers supporting product engineering effort.
Gina M. Tapper, clinical fellow and director, Center for Healthcare Excellence & Innovation, BDO
Ms. Tapper has more than 25 years of experience providing management consulting and decision support services to the health care industry. From business planning and development, to industry research and competitive positioning strategies, to cost analyses and feasibility studies, her work provides organizations with the information and planning support they need to succeed in the rapidly changing health care industry. 
Michael W. Young, principal, BiomedWoRx: Life Sciences Consulting, c-level strategist
Mr. Young’s passion is to create and deploy solutions for healthcare and life science organizations who want to do good while doing quite well. He has more than 25 years of biotech and pharma commercialization experience, including strategic marketing, specialty, oncology and anti-infective product marketing, business development, sales management and commercial operations.

Sunny Al-Shamma, PhD, president & CEO, Beacon Discovery
Dr. Al-Shamma founded Beacon Discovery in 2016 and leads an experienced drug discovery team of dedicated scientists who have worked together for more than 15 years exploiting modern advances in the science of G-Protein Coupled Receptors (GPCRs). Beacon Discovery became the HBA’s first Start-Up Tier Corporate Partner in 2018.

Groups audience: